Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dipeptidyl-Peptidase IV Inhibitors | 13 | 2024 | 311 | 2.730 |
Why?
|
Renal Insufficiency, Chronic | 15 | 2023 | 2239 | 2.650 |
Why?
|
Spinal Fractures | 6 | 2022 | 702 | 2.440 |
Why?
|
Diabetes Mellitus, Type 2 | 23 | 2024 | 12076 | 1.760 |
Why?
|
Nephrolithiasis | 2 | 2024 | 114 | 1.640 |
Why?
|
Hyperkalemia | 3 | 2024 | 231 | 1.640 |
Why?
|
Diabetic Nephropathies | 3 | 2022 | 973 | 1.320 |
Why?
|
Polypharmacy | 3 | 2021 | 305 | 1.310 |
Why?
|
Fractures, Bone | 6 | 2023 | 2040 | 1.160 |
Why?
|
Hip Fractures | 3 | 2022 | 987 | 1.150 |
Why?
|
Geriatrics | 2 | 2022 | 387 | 1.100 |
Why?
|
Nephrology | 2 | 2019 | 263 | 1.020 |
Why?
|
Hypoglycemic Agents | 18 | 2024 | 3069 | 0.980 |
Why?
|
Diabetic Ketoacidosis | 3 | 2023 | 253 | 0.960 |
Why?
|
Glucosides | 7 | 2024 | 498 | 0.870 |
Why?
|
Benzhydryl Compounds | 7 | 2024 | 900 | 0.850 |
Why?
|
Pharmacists | 3 | 2019 | 258 | 0.830 |
Why?
|
Kidney Failure, Chronic | 4 | 2021 | 2457 | 0.750 |
Why?
|
Veterans | 7 | 2023 | 2631 | 0.690 |
Why?
|
Calcium | 5 | 2023 | 5721 | 0.690 |
Why?
|
Renal Dialysis | 6 | 2021 | 1786 | 0.670 |
Why?
|
International Classification of Diseases | 2 | 2021 | 892 | 0.660 |
Why?
|
Kidney | 6 | 2023 | 7016 | 0.650 |
Why?
|
House Calls | 1 | 2020 | 160 | 0.640 |
Why?
|
Cardiovascular Diseases | 12 | 2024 | 15396 | 0.620 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 277 | 0.610 |
Why?
|
Gout | 3 | 2024 | 618 | 0.560 |
Why?
|
Histamine H2 Antagonists | 1 | 2018 | 165 | 0.560 |
Why?
|
Urinary Tract Infections | 1 | 2023 | 812 | 0.540 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2016 | 78 | 0.540 |
Why?
|
Proton Pump Inhibitors | 2 | 2018 | 529 | 0.540 |
Why?
|
Parathyroid Hormone | 3 | 2012 | 1797 | 0.530 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 209 | 0.520 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3765 | 0.510 |
Why?
|
Waist Circumference | 1 | 2019 | 922 | 0.510 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 150 | 0.490 |
Why?
|
Cohort Studies | 26 | 2024 | 41252 | 0.490 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2015 | 325 | 0.480 |
Why?
|
Wrist Injuries | 1 | 2017 | 214 | 0.470 |
Why?
|
Nephrotic Syndrome | 2 | 2015 | 391 | 0.460 |
Why?
|
Hyponatremia | 1 | 2016 | 279 | 0.450 |
Why?
|
Body Mass Index | 5 | 2024 | 12876 | 0.440 |
Why?
|
Patient Care | 1 | 2019 | 622 | 0.440 |
Why?
|
Heart Failure | 6 | 2024 | 11594 | 0.430 |
Why?
|
Aged | 40 | 2024 | 168217 | 0.420 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 408 | 0.420 |
Why?
|
Drug Prescriptions | 1 | 2021 | 1668 | 0.400 |
Why?
|
Calcium, Dietary | 2 | 2023 | 529 | 0.380 |
Why?
|
Osteoporosis | 2 | 2021 | 1599 | 0.370 |
Why?
|
Hyperthyroidism | 1 | 2012 | 291 | 0.360 |
Why?
|
Dietary Supplements | 2 | 2014 | 3388 | 0.360 |
Why?
|
Humans | 74 | 2024 | 758381 | 0.340 |
Why?
|
Medication Adherence | 2 | 2022 | 2155 | 0.340 |
Why?
|
Nurses | 3 | 2023 | 2467 | 0.340 |
Why?
|
Stroke | 5 | 2024 | 9696 | 0.330 |
Why?
|
Phosphorus | 1 | 2010 | 335 | 0.330 |
Why?
|
United States | 28 | 2024 | 72140 | 0.290 |
Why?
|
Myocardial Infarction | 4 | 2024 | 11424 | 0.290 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1852 | 0.290 |
Why?
|
Bone Density | 2 | 2017 | 3533 | 0.280 |
Why?
|
Female | 46 | 2024 | 390316 | 0.270 |
Why?
|
Glucocorticoids | 2 | 2015 | 2144 | 0.270 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2154 | 0.260 |
Why?
|
Hypoglycemia | 2 | 2023 | 881 | 0.260 |
Why?
|
Medicare | 12 | 2024 | 6741 | 0.260 |
Why?
|
Frail Elderly | 2 | 2022 | 752 | 0.250 |
Why?
|
Adult | 30 | 2024 | 219916 | 0.250 |
Why?
|
Bone Density Conservation Agents | 1 | 2012 | 794 | 0.250 |
Why?
|
Middle Aged | 32 | 2024 | 219560 | 0.240 |
Why?
|
Geriatric Assessment | 3 | 2022 | 1404 | 0.240 |
Why?
|
Prospective Studies | 11 | 2023 | 54136 | 0.230 |
Why?
|
Nutrition Surveys | 1 | 2011 | 1718 | 0.230 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 4562 | 0.230 |
Why?
|
Incidence | 10 | 2024 | 21273 | 0.230 |
Why?
|
Respiratory Aspiration | 1 | 2024 | 89 | 0.220 |
Why?
|
Atherosclerosis | 3 | 2024 | 3401 | 0.220 |
Why?
|
Algorithms | 2 | 2021 | 13959 | 0.210 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2016 | 161 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.210 |
Why?
|
Hypovolemia | 1 | 2023 | 48 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3227 | 0.200 |
Why?
|
Silicates | 1 | 2022 | 47 | 0.200 |
Why?
|
Minerals | 1 | 2023 | 283 | 0.190 |
Why?
|
Glucose | 5 | 2024 | 4336 | 0.190 |
Why?
|
Sodium | 2 | 2024 | 1588 | 0.190 |
Why?
|
Pruritus | 2 | 2015 | 377 | 0.190 |
Why?
|
Risk Assessment | 6 | 2021 | 23883 | 0.180 |
Why?
|
Hydromorphone | 1 | 2021 | 70 | 0.180 |
Why?
|
Risk Factors | 15 | 2024 | 73806 | 0.180 |
Why?
|
Snoring | 1 | 2022 | 206 | 0.180 |
Why?
|
Male | 30 | 2024 | 358742 | 0.180 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1926 | 0.170 |
Why?
|
Self Report | 3 | 2022 | 3712 | 0.170 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5105 | 0.170 |
Why?
|
Vitamin D | 4 | 2023 | 3283 | 0.170 |
Why?
|
Phosphates | 1 | 2023 | 771 | 0.170 |
Why?
|
Education, Pharmacy | 1 | 2019 | 38 | 0.170 |
Why?
|
Hypertension | 2 | 2016 | 8503 | 0.160 |
Why?
|
Hyperphosphatemia | 1 | 2019 | 39 | 0.160 |
Why?
|
Renal Insufficiency | 2 | 2023 | 809 | 0.160 |
Why?
|
Lithium | 1 | 2022 | 596 | 0.160 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2024 | 867 | 0.150 |
Why?
|
Calcium Phosphates | 1 | 2019 | 171 | 0.150 |
Why?
|
Cold Ischemia | 1 | 2018 | 67 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2023 | 907 | 0.150 |
Why?
|
Injections, Subcutaneous | 1 | 2019 | 677 | 0.150 |
Why?
|
Vitamin A | 2 | 2011 | 613 | 0.150 |
Why?
|
Chelating Agents | 1 | 2019 | 383 | 0.150 |
Why?
|
Fentanyl | 1 | 2021 | 433 | 0.150 |
Why?
|
Prospective Payment System | 1 | 2018 | 136 | 0.140 |
Why?
|
Hearing | 1 | 2021 | 501 | 0.140 |
Why?
|
Publication Bias | 1 | 2017 | 161 | 0.140 |
Why?
|
Thrombotic Microangiopathies | 1 | 2018 | 123 | 0.140 |
Why?
|
Pilot Projects | 2 | 2020 | 8554 | 0.140 |
Why?
|
Hospice Care | 1 | 2023 | 677 | 0.130 |
Why?
|
Diphosphonates | 1 | 2021 | 636 | 0.130 |
Why?
|
Pyrazoles | 2 | 2023 | 1990 | 0.130 |
Why?
|
Hyperparathyroidism | 1 | 2017 | 337 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 907 | 0.130 |
Why?
|
Proteinuria | 2 | 2015 | 594 | 0.120 |
Why?
|
Tissue and Organ Harvesting | 1 | 2018 | 373 | 0.120 |
Why?
|
Administration, Oral | 2 | 2021 | 3993 | 0.120 |
Why?
|
Polymers | 1 | 2022 | 1615 | 0.120 |
Why?
|
Hospitalization | 4 | 2024 | 10653 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1141 | 0.120 |
Why?
|
Body Size | 1 | 2017 | 462 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2024 | 986 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12951 | 0.110 |
Why?
|
Drug Interactions | 1 | 2018 | 1414 | 0.110 |
Why?
|
Comorbidity | 2 | 2020 | 10495 | 0.110 |
Why?
|
Hearing Loss | 1 | 2021 | 780 | 0.110 |
Why?
|
Spine | 1 | 2020 | 1111 | 0.110 |
Why?
|
Interprofessional Relations | 1 | 2019 | 989 | 0.110 |
Why?
|
Dermatomyositis | 1 | 2016 | 256 | 0.110 |
Why?
|
Interviews as Topic | 1 | 2020 | 2675 | 0.110 |
Why?
|
Suicide, Attempted | 1 | 2022 | 1383 | 0.110 |
Why?
|
Bone and Bones | 1 | 2023 | 2560 | 0.100 |
Why?
|
Inpatients | 1 | 2024 | 2551 | 0.100 |
Why?
|
Ultraviolet Rays | 1 | 2017 | 1076 | 0.100 |
Why?
|
Sulfonylurea Compounds | 2 | 2023 | 219 | 0.100 |
Why?
|
Kidney Calculi | 1 | 2015 | 468 | 0.090 |
Why?
|
Transplantation Conditioning | 1 | 2018 | 1588 | 0.090 |
Why?
|
Retrospective Studies | 9 | 2024 | 80170 | 0.090 |
Why?
|
Age Factors | 3 | 2019 | 18357 | 0.090 |
Why?
|
Sex Factors | 2 | 2017 | 10505 | 0.090 |
Why?
|
Creatinine | 3 | 2023 | 1892 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3175 | 0.090 |
Why?
|
Mexican Americans | 1 | 2011 | 165 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14481 | 0.090 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2018 | 0.090 |
Why?
|
Uric Acid | 2 | 2016 | 803 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10146 | 0.080 |
Why?
|
Aspirin | 1 | 2021 | 3132 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3527 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2019 | 2083 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8823 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58681 | 0.070 |
Why?
|
Adolescent | 4 | 2024 | 87888 | 0.070 |
Why?
|
Lung Diseases, Interstitial | 1 | 2016 | 909 | 0.070 |
Why?
|
Pyridones | 2 | 2023 | 785 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2882 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2920 | 0.070 |
Why?
|
Demography | 1 | 2011 | 1651 | 0.070 |
Why?
|
Health Surveys | 1 | 2016 | 4060 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7980 | 0.070 |
Why?
|
Sleep | 1 | 2022 | 4745 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15225 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4426 | 0.060 |
Why?
|
Diet | 2 | 2014 | 8003 | 0.060 |
Why?
|
Bipolar Disorder | 1 | 2022 | 5083 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5818 | 0.060 |
Why?
|
Propensity Score | 2 | 2024 | 1907 | 0.060 |
Why?
|
Seasons | 1 | 2010 | 1519 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9599 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4745 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3806 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 2244 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15646 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4217 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5403 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12096 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 39873 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14641 | 0.050 |
Why?
|
Iohexol | 1 | 2023 | 204 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2022 | 91 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 25953 | 0.050 |
Why?
|
Nurse's Role | 1 | 2023 | 188 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10747 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12440 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 5952 | 0.050 |
Why?
|
Cystatin C | 1 | 2023 | 270 | 0.050 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2021 | 89 | 0.050 |
Why?
|
Hydrochlorothiazide | 1 | 2021 | 94 | 0.050 |
Why?
|
Milk | 1 | 2023 | 443 | 0.050 |
Why?
|
Audiometry | 1 | 2021 | 253 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.040 |
Why?
|
Dairy Products | 1 | 2023 | 491 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5649 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3886 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 58808 | 0.040 |
Why?
|
Coronary Disease | 1 | 2014 | 5917 | 0.040 |
Why?
|
Health Status | 1 | 2012 | 4069 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5788 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2024 | 715 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 520 | 0.040 |
Why?
|
Anticoagulants | 2 | 2023 | 4778 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 907 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1110 | 0.030 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2016 | 94 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39060 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2016 | 149 | 0.030 |
Why?
|
Maine | 1 | 2016 | 145 | 0.030 |
Why?
|
Warfarin | 1 | 2023 | 1482 | 0.030 |
Why?
|
Furosemide | 1 | 2015 | 170 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3674 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2210 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1277 | 0.030 |
Why?
|
Mortality | 1 | 2024 | 2885 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1430 | 0.020 |
Why?
|
Health Care Costs | 1 | 2024 | 3245 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 64379 | 0.020 |
Why?
|
Calcinosis | 1 | 2019 | 1467 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4341 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4839 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3915 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6578 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3060 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3794 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12262 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 6154 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10112 | 0.020 |
Why?
|
Registries | 1 | 2018 | 8176 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29558 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12870 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12721 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6363 | 0.010 |
Why?
|
Animals | 1 | 2023 | 167777 | 0.010 |
Why?
|
Concepts
(237)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_